Aurobindo Pharma gets USFDA nod for anti-HIV tablets
New Delhi: Drug firm Aurobindo Pharma has received tentative approval from the US health regulator for its Ritonavir tablets used for treatment of human immunodeficiency virus (HIV) infection.
The United States Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma's Ritonavir tablets in the strength of 100 mg, FDA said on its website.
Established in 1986, Aurobindo Pharma is present in semi-synthetic penicillins and therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
The United States Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma's Ritonavir tablets in the strength of 100 mg, FDA said on its website.
Established in 1986, Aurobindo Pharma is present in semi-synthetic penicillins and therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.